Leqembi® Iqlik™ (lecanemab-irmb) maintenance treatment launched in the U.S.

STOCKHOLM, Oct. 6, 2025 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that lecanemab-irmb subcutaneous injection (U.S. brand…